NEW YORK, July 9 - Millennium Pharmaceuticals has agreed to license the BioRS data integration and retrieval system from Biomax, the companies said Monday. 

BioRS integrates public and proprietary biological databases through a web interface. The system uses XML to standardize the data format, and can integrate both relational and flat-file databases. In January, Informax signed a four-year deal with Biomax, based in Martinsried, to exclusively license and distribute the BioRS system worldwide.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.